United States · FDA National Drug Code directory
Duloxetine Delayed-Release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51991-750_32327581-bdab-41ac-9adc-bf208e1c4e42
- Product NDC
- 51991-750
- Form
- CAPSULE, DELAYED RELEASE PELLETS
- Composition / generic term
- DULOXETINE HYDROCHLORIDE
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180521
- Source listing expiry
- 20261231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (51991-750-05) · 51991-750-05
- 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (51991-750-10) · 51991-750-10
- 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (51991-750-33) · 51991-750-33
- 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (51991-750-90) · 51991-750-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →